|
NUCRYST Pharmaceuticals develops, manufactures and commercializes medical products that fight infection and inflammation based on its patented atomically disordered nanocrystalline silver technology.
NUCRYST's common shares are traded on NASDAQ under the symbol NCST and on The Toronto Stock Exchange under the symbol NCS.
|
